* Ronapreve, Known as REGEN-COV in The United States, Is a Combination of Two Monoclonal Antibodies That Bind to SARS-CoV-2, The Virus That Causes COVID19 .
- This Binding Prevents The Virus From Infection Cells in the Lining of The Respiratory Tract .
- The Drug Regulator in the United Kingdom has Approved Ronapreve, Which Regeneron and Roche developed, fory Both Prevention and Treatment .
- Research Suggests that Administering the Antibodie Combo Soon After Symptoms Develop can Reduce the Chances of Hospitalization and Death .
